Therapeutic Vaccination in Lung Cancer: Past Attempts, Current Approaches and Future Promises.

J Respir Biol Transl Med · 2025 · PMC12803744 · PMID 41542091

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Phase I and II clinical trials of MAGEA3 peptide-based vaccines in patients with completely resected stage IB-II NSCLC demonstrated safety and showed a trend toward improved disease-free interval (DFI) and disease-free survival (DFS) [ 119 , 120 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.